Weekly nab-paclitaxel plus carboplatin as neoadjuvant therapy for IIIA-N2 lung squamous cell carcinoma: A prospective phase II study.

被引：1
|
作者：
Zhu, Jian-Quan
Zhang, Yu
Yue, Dongsheng
Zhao, Xiaoliang
Zhang, Qiang
Chen, Hui
Wang, Changli
机构：
[1] Tianjin Canc Hosp, Tianjin, Peoples R China
[2] Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e20501
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20501
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Paclitaxel and carboplatin as neoadjuvant chemotherapy in operable (stage I and II) and locally advanced (stage IIIA-N2) non-small cell lung cancer
    Splinter, TAW
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 59 - 61
  • [42] A pilot phase II trial of neoadjuvant camrelizumab plus nab-paclitaxel and cisplatin (NeoCPC) for locoregionally advanced, resectable squamous cell carcinoma of the head and neck.
    Wu, Di
    Li, Yong
    Xu, Peng-Fei
    Zhang, Xinrui
    Lin, Hongsheng
    Li, Yin
    Fang, Qi
    Cao, Fei
    Su, Yong
    Lu, Li-Xia
    Li, Yizhuo
    Zhao, Zheng
    Hong, Xiaoyu
    Li, Guohong
    Yan, Honghong
    Fan, Yunyun
    Chen, Lei
    Li, Zhiming
    Liu, Xuekui
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [43] Phase II trial of weekly nab-paclitaxel and carboplatin treatment with or without trastuzumab as nonanthracycline neoadjuvant chemotherapy for locally advanced breast cancer
    Huang, Liang
    Chen, Sheng
    Yao, Ling
    Liu, Guangyu
    Wu, Jiong
    Shao, Zhiming
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2015, 10 : 1969 - 1975
  • [44] Phase II trial of combination nab-paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma
    Ajjai Alva
    Stephanie Daignault
    David C. Smith
    Maha Hussain
    Investigational New Drugs, 2014, 32 : 188 - 194
  • [45] Phase I Study of Nab-Paclitaxel plus Gemcitabine as Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer
    Okada, Ken-Ichi
    Hirono, Seiko
    Kawai, Manabu
    Miyazawa, Motoki
    Shimizu, Atsushi
    Kitahata, Yuji
    Ueno, Masaki
    Hayami, Shinya
    Yamaue, Hiroki
    ANTICANCER RESEARCH, 2017, 37 (02) : 853 - 858
  • [46] Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study
    Lei Gong
    Weimin Mao
    Qixun Chen
    Youhua Jiang
    Yun Fan
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 639 - 647
  • [47] Phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy for patients with locally advanced non-small cell lung cancer
    Kawano, Yuko
    Sasaki, Tomonari
    Yamaguchi, Hiroyuki
    Hirano, Katsuya
    Horiike, Atsushi
    Satouchi, Miyako
    Hosokawa, Shinobu
    Morinaga, Ryotaro
    Komiya, Kazutoshi
    Inoue, Koji
    Fujita, Yuka
    Toyozawa, Ryo
    Kimura, Tomoki
    Takahashi, Kosuke
    Nishikawa, Kazuo
    Kishimoto, Junji
    Nakanishi, Yoichi
    Okamoto, Isamu
    LUNG CANCER, 2018, 125 : 136 - 141
  • [48] Phase I study of weekly nab-paclitaxel plus weekly cetuximab plus intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)
    Fury, M. G.
    Sherman, E. J.
    Rao, S. S.
    Wolden, S.
    Smith-Marrone, S.
    Mueller, B.
    Ng, K. K.
    Dutta, P. R.
    Gelblum, D. Y.
    Lee, J. L.
    Shen, R.
    Kurz, S.
    Katabi, N.
    Haque, S.
    Lee, N. Y.
    Pfister, D. G.
    ANNALS OF ONCOLOGY, 2014, 25 (03) : 689 - 694
  • [49] A phase II study of nab-paclitaxel plus carboplatin in combination with thoracic radiation in patients with locally advanced non-small-cell lung cancer
    Hasegawa, Takaaki
    Futamura, Yohei
    Horiba, Akane
    Yoshida, Tsutomu
    Suzuki, Toshitaka
    Kato, Tatsuo
    Kaito, Daizo
    Ohno, Yasuhi
    Iida, Takayoshi
    Hayashi, Shinya
    Sawa, Toshiyuki
    JOURNAL OF RADIATION RESEARCH, 2016, 57 (01) : 50 - 54
  • [50] Phase II trial of combination nab-paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma
    Alva, Ajjai
    Daignault, Stephanie
    Smith, David C.
    Hussain, Maha
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (01) : 188 - 194
12345